TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy

Human Molecular Genetics

Volumn 23, Issue 21, 2014, Pages 5793-5804

  Theis, Jeanne L ^a   Zimmermann, Michael T ^a   Larsen, Brandon T ^a   Rybakova, Inna N ^c   Long, Pamela A ^a   Evans, Jared M ^a   Middha, Sumit ^a   de Andrade, Mariza ^a   Moss, Richard L ^c   Wieben, Eric D ^b   Michels, Virginia V ^a   Olson, Timothy M ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; TNNI3K PROTEIN; TROPONIN I; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ORGANIC COMPOUND; PHEN GREEN SK; TNNI3K PROTEIN, HUMAN;

ADULT; ARTICLE; CHROMOSOME; CHROMOSOME 13Q12; CHROMOSOME 1P3; CLINICAL ARTICLE; COMPUTER MODEL; CONGESTIVE CARDIOMYOPATHY; GENE MUTATION; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART DISEASE; HEART FUNCTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LINKAGE ANALYSIS; MALE; MIDDLE AGED; MISSENSE MUTATION; PHENOTYPE; PROTEIN DEFICIENCY; TACHYCARDIA; ABNORMALITIES; AMINO ACID SEQUENCE; ARRHYTHMIAS, CARDIAC; CARDIAC MUSCLE; CARDIOMYOPATHY, DILATED; CHEMICAL STRUCTURE; CHEMISTRY; CHILD; CHROMOSOMAL MAPPING; CHROMOSOME 1; CONSERVED SEQUENCE; EXOME; FEMALE; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; GENETICS; HAPLOTYPE; HEART MUSCLE CONDUCTION SYSTEM; HIGH THROUGHPUT SEQUENCING; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PEDIGREE; PROTEIN CONFORMATION; PROTEIN DOMAIN; SEQUENCE ALIGNMENT; SYNDROME; TACHYCARDIA, ECTOPIC ATRIAL; ULTRASTRUCTURE;

ADULT; AMINO ACID SEQUENCE; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CONSERVED SEQUENCE; EXOME; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC VARIATION; HAPLOTYPES; HEART CONDUCTION SYSTEM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MAP KINASE KINASE KINASES; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; MYOCARDIUM; ORGANIC CHEMICALS; PEDIGREE; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE ALIGNMENT; SYNDROME; TACHYCARDIA, ECTOPIC ATRIAL;

EID: 84911374570     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu297     Document Type: Article

References (39)

1. Lloyd-Jones, D.M., Wang, T.J., Leip, E.P., Larson, M.G., Levy, D., Vasan, R.S., D'Agostino, R.B., Massaro, J.M., Beiser, A., Wolf, P.A. et al. (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 110, 1042-1046.
2. Darbar, D., Herron, K.J., Ballew, J.D., Jahangir, A., Gersh, B.J., Shen, W.-K., Hammill, S.C., Packer, D.L. and Olson, T.M. (2003) Familial atrial fibrillation isagenetically heterogeneous disorder.J. Am. Coll. Cardiol., 41, 2185-2192.
3. Chen, Y.H., Xu, S.J., Bendahhou, S., Wang, X.L., Wang, Y., Xu, W.Y., Jin, H.W., Sun, H., Su, X.Y., Zhuang, Q.N. et al. (2003) KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science, 299, 251-254.
4. Hodgson-Zingman, D.M., Karst, M.L., Zingman, L.V., Heublein, D.M., Darbar, D., Herron, K.J., Ballew, J.B., de Andrade, M., Burnett, J.C. and Olson, T.M. (2008) Atrial natriuretic peptide frameshift mutationin familial atrial fibrillation. New Engl. J. Med., 359, 158-165.
5. Zhang, X., Chen, S., Yoo, S., Chakrabarti, S., Zhang, T., Ke, T., Oberti, C., Yong, S.L., Fang, F., Li, L. et al. (2008) Mutationinnuclear pore component NUP155 leadsto atrialfibrillation and early sudden cardiac death. Cell, 135, 1017-1027.
6. Karst, M.L., Herron, K.J. and Olson, T.M. (2005) X-linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by Emerin mutation. J. Cardiovasc. Electrophysiol., 19, 510-515.
7. Olson, T.M., Michels, V.V., Ballew, J.D., Reyna, S.P., Karst, M.L., Herron, K.J., Horton, S.C., Rodeheffer, R.J. and Anderson, J.L. (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA, 293, 447-454.
8. Fatkin, D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J., Spudich, S., De Girolami, U. et al. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med., 341, 1715-1724.
9. Theis, J.L., Sharpe, K.M., Matsumoto, M.E., Chai, H.S., Nair, A.A., Theis, J.D., de Andrade, M., Wieben, E.D., Michels, V.V. and Olson, T.M. (2011) Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy. Circ. Cardiovasc. Genet., 4, 585-594.
10. Zhao, Y., Meng, X.M., Wei, Y.J., Zhao, X.W., Liu, D.Q., Cao, H.Q., Liew, C.C. and Ding, J.F. (2003) Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J. Mol. Med., 81, 297-304.
11. Wheeler, F.C., Tang, H., Marks, O.A., Hadnott, T.N., Chu, P.L., Mao, L., Rockman, H.A. and Marchuk, D.A. (2009) TNNI3K modifies disease progression in murine models of cardiomyopathy. PLoS Genet., 5, 1-11.
12. Tang, H., Xiao, K., Mao, L., Rockman, H.A. and Marchuk, D.A. (2013) Over expression of TNNI3K, acardiac-specific MAPKKK, promotescardiac dysfunction. J. Mol. Cell. Cardiol., 54, 101-111.
13. Vagnozzi, R.J., Gatto, G.J. Jr, Kallander, L.S., Hoffman, N.E., Mallilankaraman, K., Ballard, V.L.T., Lawhorn, B.G., Stoy, P., Philp, J., Graves, A.P. et al. (2013) Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart. Sci. Transl. Med., 5, 1-12.
14. Lodder, E.M., Scicluna, B.P., Milano, A., Sun, A.Y., Tang, H., Remme, C.A.,Moerland,P.D.,Tanck,M.W.T.,Pitt,G.S.,Marchuk, D.A.etal.(2012) Dissection of a quantitative trait locus for PR interval duration identifies TNNI3K as a novel modulator of cardiac conduction. PLoS Genet., 8, 1-8.
15. Lai, Z.F., Chen, Y.Z., Chen, J., Tsuda, H., Kitamoto, Y. and Kim-Mitsuyama, S. (2012) Mutation of TNNI3K gene increased incidence of arrhythmias in culture cardiomyocytes and in vivo mouse hearts. Circulation, 126, A31. Resuscitation Science Symposium. Abstract.
16. Ng, P.C. and Henikoff, S. (2001) Predicting deleterious amino acid substitutions. Genome Res., 11, 863-874.
17. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
18. Lai, Z.F.,Chen,Y.Z.,Feng, L.P.,Meng,X.M.,Ding, J.F.,Wang,L.Y., Ye, J., Li, P., Cheng, X.S., Kitamoto,Y. et al. (2008) OverexpressionofTNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury. Am. J. Physiol. Heart Circ. Physiol., 295, H708-H716.
19. Wang, X., Wang, J., Su, M., Wang, C., Chen, J., Wang, H., Song, L., Zou, Y., Zhang, L., Zhang, Y. et al. (2013) TNNI3K, a cardiac-specific kinase, promotes physiological cardiac hypertrophy in transgenic mice. PLoS One, 8, 1-11.
20. Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S. and Goldstein, D.B. (2013) Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet., 9, 1-13.
21. Baker, N.A., Sept, D., Joseph, S., Holst, M.J. and McCammon, J.A. (2001) Electrostaticsofnanosystems:applicationtomicrotubulesand theribosome. Proc. Natl. Acad. Sci. USA, 98, 10037-10041.
22. Feng, Y., Cao, H.Q.,Liu, Z., Ding,J.F. andMeng,X.M. (2007) Identification of the dual specificity and the functional domains of the cardiac-specific protein kinase TNNI3K. Gen. Physiol. Biophys., 26, 104-109.
23. Van Durme, J., Delgado, J., Stricher, F., Serrano, L., Schymkowitz, J. and Rousseau, F. (2011) A graphical interface for the FoldX forcefield. Bioinformatics, 27, 1711-1712.
24. Olson, T.M., Alekseev, A.E., Moreau, C., Liu, X.K., Zingman, L.V., Miki, T., Seino, S., Asirvatham, S.J., Jahangir, A. and Terzic, A. (2007) KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med., 4, 110-116.
25. McNally, E.M., Golbus, J.R. and Puckelwartz, M.J. (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest., 123, 19-26.
26. Meijering, R.A.M., Zhang, D., Hoogstra-Berends, F., Henning, R.H. and Brundel, B.J.J.M. (2012) Loss of proteostatic control as a substrate for atrial fibrillation:anovel targetfor upstreamtherapybyheat shock proteins.Front. Physiol., 3, 1-11.
27. Rajasekaran, N.S., Connell, P., Christians, E.S., Yan, L.J., Taylor, R.P., Orosz, A., Zhang, X.Q., Stevenson, T.J., Peshock, R.M., Leopold, J.A. et al. (2007) Human ab-crystallin mutation causes oxido-reductive stress and protein aggregation in cardiomyopathy in mice. Cell, 130, 427-439.
28. Henry, W.L., Gardin, J.M. and Ware, J.H. (1980) Echocardiographic measurements in normal subjects from infancy to old age. Circulation, 62, 1056-1061.
29. Sobel, E. and Lange, K. (1996) Descent graphs in pedigree analysis: application to haplotyping, location scores, and marker sharing statistics. Am. J. Hum. Genet., 58, 1323-1337.
30. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M. et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res., 20, 1297- 1303.
31. DePristo, M.A., Banks, E., Poplin, R.E., Garimella, K.V., Maquire, J.R., Hartl, C., Philippakis, A.A., del Angel, G., Rivas, M.A., Hanna, M. et al.(2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet., 43, 491-498.
32. The 1000 Genomes Consortium. (2012) An integrated map of genetic variation from 1092 human genomes. Nature, 491, 56-65.
33. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle,WA (URL: http://eversusgs.washington.edu/EVS/) [October 2013].
34. Drmanac, R., Sparks, A.B., Callow, M.J., Halpern, A.L., Burns, N.L., Kermani, B.G., Carnevali, P., Nazarenko, I., Nilsen, G.B., Yeung, G. et al. (2010) Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science, 327, 78-81.
35. Kiefer, F., Arnold, K., Kunzli, M., Bordoli, L. and Schwede, T. (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Res., 37, D387-D392.
36. Comeau, S.R., Gatchell, D.W., Vajda,S.and Camacho, C.J. (2004) ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res., 32, W96-W99.
37. Kozakov, D., Beglov, D., Bohnuud, T., Mottarella, S.E., Xia, B., Hall, D.R. and Vajda, S. (2013) How good is automated protein docking? Proteins, 81, 2159-2166.
38. Olson, T.M., Kishimoto, N.Y., Whitby, F.G. and Michels, V.V. (2001) Mutations that alter the surface of alpha-tropomyosin are associated with dilated cardiomyopathy. J. Mol. Cell Cardiol., 33, 723-732.
39. Brauch, K.M., Karst, M.L., Herron, K.J., de Andrade, M., Pellikka, P.A., Rodeheffer, R.J., Michels, V.V. and Olson, T.M. (2009) Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J. Am. Coll. Cardiol., 54, 930-941.